ArticleCancer management and research2017

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cell.

Jiachi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.